Duplessis C, Clarkson KA, Ross Turbyfill K, Alcala AN, et al. GMP manufacture of Shigella flexneri 2a Artificial Invaplex (Invaplex(AR)) and evaluation in a Phase 1 Open-label, dose escalating study administered intranasally to healthy, adult volunteers. Vaccine 2023;41:6261-6271.
PMID: 37666695